Terms: = Gastric cancer AND KTN1, Q86UP2, 3895, ENSG00000126777, KIAA0004, CG1 AND Treatment
3 results:
1. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
Li JX; Sun L; Zhao S; Shao B; Guo YH; Chen S; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):346-356. PubMed ID: 37072312
[No Abstract] [Full Text] [Related]
2. M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted gastric cancers.
Ohashi Y; Okamura M; Hirosawa A; Tamaki N; Akatsuka A; Wu KM; Choi HW; Yoshimatsu K; Shiina I; Yamori T; Dan S
Cancer Res; 2016 Jul; 76(13):3895-903. PubMed ID: 27197184
[TBL] [Abstract] [Full Text] [Related]
3. [The natural course of early gastric cancer].
Jeong SH; Park MI; Kim HH; Park SJ; Moon W
Korean J Gastroenterol; 2012 Oct; 60(4):224-8. PubMed ID: 23089908
[TBL] [Abstract] [Full Text] [Related]
